Patient Square-Backed Enavate Adds Edward Fleming Jr.
Enavate Sciences has added Edward Fleming Jr. as executive vice president of commercialization.
Stay updated with breaking news from Enavate Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Enavate Sciences has added Edward Fleming Jr. as executive vice president of commercialization.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Investegate announcements from Zenas BioPharma, Zenas BioPharma Secures $118 Million to Advance Its Broad Pipeline of Autoimmune Disease Therapeutics
Proceeds to fund global Phase 3 registration program for the company's lead product candidate, Obexelimab, and support the clinical development of other pipeline programsSeries B equity financing led by
Biotechnology company CAMP4 Therapeutics has closed a $100m Series B round to progress its lead regRNA programmes and speed up the expansion of its regRNA Actuating Platform.